Literature DB >> 12350189

Economic and health consequences of selling a kidney in India.

Madhav Goyal1, Ravindra L Mehta, Lawrence J Schneiderman, Ashwini R Sehgal.   

Abstract

CONTEXT: Many countries have a shortage of kidneys available for transplantation. Paying people to donate kidneys is often proposed or justified as a way to benefit recipients by increasing the supply of organs and to benefit donors by improving their economic status. However, whether individuals who sell their kidneys actually benefit from the sale is controversial.
OBJECTIVE: To determine the economic and health effects of selling a kidney. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional survey conducted in February 2001 among 305 individuals who had sold a kidney in Chennai, India, an average of 6 years before the survey. MAIN OUTCOME MEASURES: Reasons for selling kidney, amount received from sale, how money was spent, change in economic status, change in health status, advice for others contemplating selling a kidney.
RESULTS: Ninety-six percent of participants sold their kidneys to pay off debts. The average amount received was 1070 US dollars. Most of the money received was spent on debts, food, and clothing. Average family income declined by one third after nephrectomy (P<.001), and the number of participants living below the poverty line increased. Three fourths of participants were still in debt at the time of the survey. About 86% of participants reported a deterioration in their health status after nephrectomy. Seventy-nine percent would not recommend that others sell a kidney.
CONCLUSIONS: Among paid donors in India, selling a kidney does not lead to a long-term economic benefit and may be associated with a decline in health. Physicians and policy makers should reexamine the value of using financial incentives to increase the supply of organs for transplantation.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  2002        PMID: 12350189     DOI: 10.1001/jama.288.13.1589

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  40 in total

1.  Payment for living organ donation should be legalised.

Authors:  Amy L Friedman
Journal:  BMJ       Date:  2006-10-07

Review 2.  The state of the international organ trade: a provisional picture based on integration of available information.

Authors:  Yosuke Shimazono
Journal:  Bull World Health Organ       Date:  2007-12       Impact factor: 9.408

3.  'Medical tourism' initiatives should exclude commercial organ transplantation.

Authors:  Leigh Turner
Journal:  J R Soc Med       Date:  2008-08       Impact factor: 5.344

4.  Transplant tourism: a growing phenomenon.

Authors:  David J Cohen
Journal:  Nat Clin Pract Nephrol       Date:  2009-01-27

5.  Kidney sales and the analogy with dangerous employment.

Authors:  Erik Malmqvist
Journal:  Health Care Anal       Date:  2015-06

6.  Focus group study of public opinion about paying living kidney donors in Australia.

Authors:  Allison Tong; Angelique F Ralph; Jeremy R Chapman; Germaine Wong; John S Gill; Michelle A Josephson; Jonathan C Craig
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-23       Impact factor: 8.237

7.  Should we pay donors to increase the supply of organs for transplantation? No.

Authors:  Jeremy Chapman
Journal:  BMJ       Date:  2008-06-14

Review 8.  Key issues in transplant tourism.

Authors:  Jacob A Akoh
Journal:  World J Transplant       Date:  2012-02-24

9.  The Mississippi decision exchanging parole for kidney donation: is this the beginning of change for altruistic-based human organ donation policy in the United States?

Authors:  Christopher M Burkle
Journal:  Mayo Clin Proc       Date:  2011-03-30       Impact factor: 7.616

10.  The declaration of Istanbul in the Philippines: success with foreigners but a continuing challenge for local transplant tourism.

Authors:  Leonardo D de Castro
Journal:  Med Health Care Philos       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.